Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr707 Inhibitors

Olr707 inhibitors represent a class of chemical compounds that specifically target the olfactory receptor 707 (Olr707), a protein found within the olfactory system responsible for detecting odor molecules. These inhibitors interact with the Olr707 receptor at the molecular level, typically binding to its active site or altering its conformation, thereby modulating its activity. The intricate interaction between these inhibitors and Olr707 involves a range of binding mechanisms, including hydrogen bonding, van der Waals forces, and hydrophobic interactions. The structure-activity relationship (SAR) studies of Olr707 inhibitors provide insight into the molecular features essential for high-affinity binding and effective inhibition, revealing the importance of specific functional groups and molecular geometries.

The development and study of Olr707 inhibitors involve advanced techniques in chemical synthesis and analytical chemistry. Researchers employ methods such as high-throughput screening (HTS) to identify potential inhibitors from vast chemical libraries, followed by rigorous characterization using techniques like nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. Computational modeling and molecular docking studies further enhance understanding of the binding interactions at an atomic level. By elucidating the precise binding modes and conformational changes induced by these inhibitors, scientists gain valuable insights into the fundamental processes governing olfactory signal transduction. The study of Olr707 inhibitors not only advances the knowledge of olfactory receptor function but also contributes to the broader field of sensory biology, providing a deeper comprehension of how organisms perceive and interpret chemical signals in their environment.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Exemestane

107868-30-4sc-203045
sc-203045A
25 mg
100 mg
$134.00
$411.00
(0)

Aromatase inhibitor, potentially affecting estrogen synthesis and related signaling proteins.

Raloxifene

84449-90-1sc-476458
1 g
$802.00
3
(0)

Selective estrogen receptor modulator, potentially influencing proteins in estrogen receptor signaling pathways.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual inhibitor of EGFR and HER2, potentially affecting proteins in associated signaling pathways.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

MEK inhibitor, potentially disrupting proteins in the MAPK/ERK pathway.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

MEK inhibitor, potentially affecting proteins involved in the MAPK/ERK pathway.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGF receptors, potentially affecting proteins involved in angiogenesis and tumor growth.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR tyrosine kinase inhibitor, potentially affecting proteins in the EGFR signaling pathway.

Sotrastaurin

425637-18-9sc-474229
sc-474229A
5 mg
10 mg
$300.00
$540.00
(0)

Protein kinase C inhibitor, potentially influencing proteins in cell signaling pathways.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$156.00
$572.00
(1)

HDAC inhibitor, potentially impacting gene expression and chromatin remodeling proteins.

Apalutamide

956104-40-8sc-507442
5 mg
$290.00
(0)

Androgen receptor antagonist, potentially affecting proteins in androgen receptor signaling pathways.